Cell surface binding characteristics correlate with consensus type I interferon enhanced activity

Journal of Interferon and Cytokine Research

Volumn 16, Issue 1, 1996, Pages 1-6

  Klein, Susan B ^a   Blatt, Lawrence M ^b   Taylor, Milton W ^a  

^a INDIANA UNIVERSITY   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CONSENSUS INTERFERON; GAMMA INTERFERON; INTERFERON; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG ACTIVITY; DRUG BINDING SITE; DRUG POTENCY; GENETIC ENGINEERING; INTERNALIZATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY;

EID: 0030032919     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.1     Document Type: Article

References (40)

1. REVEL, M. (1984). The Interferon Molecules and Mode of Action in Antiviral Drugs and Interferon: The Molecular Basis of Their Action. Boston: M. Nijhoff, pp. 102-157.
2. DAVIS, J.M., NARACHI, M.A., LEVINE, H.L., ALTON, N.K., and ARAKAWA, T. (1987). Conformation and stability of two recombinent human interferon-α analogs. J. Peptide Protein Res. 29, 685-091.
3. OZES, O.N., REITER, Z., KLEIN, S., BLATT, LM., and TAYLOR, M.W. (1992). A comparison of interferon-con1 with natural recombinant interferons-α: antiviral, antiproliferative and natural killer-inducing activities. J Interferon Res. 12, 55-59.
4. LUTFALLA, G., GARDINER, K., PROUDHON, D., VIEHL, E., and UZE, G. (1992). The structure of the human interferon α/β receptor gene. J. Biol. Chem. 267, 2802-2809.
5. FISH, E.N. (1992). Definition of receptor binding domains in interferon-α. J. Interferon Res. 12, 257-266.
6. KLEIN, S.B., BLATT, L., and TAYLOR, M.W. (1993). Consensus interferon induces peak accumulation at lower concentrations than interferon-2a. J. Interferon Res. 13, 341-347.
7. BENOIT, P., MAGUIRE, D., PLAVEC, I., KOCHER, H., TOVEY, M., and MEYER, F. (1993). A monoclonal antibody to recombinant human IFN-α receptor inhibits biologic activity of several species of human IFN-α, IFN-β and IFN-ω. J. Immunol. 150, 707-716.
8. BRANCA, A.A., and BAGLIONI, C. (1981). Evidence that types I and II interferons have different receptors. Nature 294, 768-770.
9. FISH, E.N., BANERJEE, K., and STEBBING, N. (1989). The role of three domains in the biological activity of human interferon-α. J. Interferon Res. 9, 97-114.
10. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon α/β receptor: Characterization and molecular cloning. Cell 77, 391-400.
11. AGUET, M., GROBKE, M., and DREIDING, P. (1984). Various human interferon-α subclasses cross-react with common receptors: their binding affinities correlate with their specific biological activities. Virology 132, 211-216.
12. EVINGER, M., RUBINSTEIN, M., and PESTKA, S. (1981). Antiproliferative and antiviral activities of human leukocyte interferons. Arch. Biochem. Biophys. 210, 319-329.
13. VERHAGEN, A., MACKAY, I.R., ROWLEY, M., and TYMMS, M. (1990). Comparison of augmentation of human natural killer cell cytotoxicity by interferon-alpha subtypes. Nat. Immun. Cell Growth Regul. 9, 325-333.
14. KERR, I.M., and STARK, G.R. (1992). The antiviral effects of the interferons and their inhibition. J. Interferon Res. 12, 237-240.
15. WRECK, P.K., APPERSON, S., MAY, L., and STEBBING, N. (1981) Comparison of the antiviral activities of various cloned human interferon-α subtypes in mammalian cell cultures. J. Gen. Virol. 57, 233-237.
16. RUBINSTEIN, M., LEVY, W.P., MOSCHERA, J.A., LAI, C.Y., HERSHBERG, R.D., BARTLETT, R.T., and PESTKA, S. (1981). Human leukocyte interferon: isolation and characterization of several molecular forms. Arch. Biochem. Biophys. 210, 307-318.
17. KLEIN, S.B., OZES, O.N., REITER, Z., and TAYLOR, M.W. (1994). Cell surface determination of type I interferon biological activity. J. Cell. Biol. 18B, 239.
18. HUEZ, G., SILHOL, M., and LEBLEU, B. (1983). Microinjected interferon does not promote an antiviral response in HeLa cells. Biochem. Biophys. Res. Commun. 110, 155-160.
19. VENGRIS, V.E., STOLLAR, B.D., and PITHA, P.M. (1975). Interferon externalization by producing cell before induction of antiviral state. Virology 65, 410-417.
20. SCATCHARD, G. (1949). The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660-672.
21. HANNIGAN, G., and WILLIAMS, B.R.G. (1986). Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy. EMBO J. 5, 1607-1613.
22. AGUET, M. (1991). Molecular cloning of interferon receptors: a short review. Br. J. Haematol. 79, 6-8.
23. MOGENSEN, K.E., VIGNAUX, R, and GRESSLER, I. (1982). Enhanced expression of cellular receptors for human interferon α on peripheral lymphocytes from patients with Down's syndrome. FEBS Lett. 140, 285-287.
24. ZOON, K.C., ZUR NEDDEN, D., and ARNHEITER, H. (1982). Specific binding of human alpha interferon to a high affinity receptor site of bovine kidney cells. J. Biol. Chem. 257, 4695-4697.
25. ESTELLE, K.E., and POWERS, M.T. (1983). Cellular binding characteristics of human interferon. Virology 57, 378-386.
26. EPSTEIN, C.J., McMANUS, N.H., EPSTEIN, L.B., BRANCA, A.A., D'ALESSANDRO, S.B., and BAGLIONI, C. (1982). Direct evidence that the gene product of the human chromosome 21 locus, IFRC, is the interferon-α receptor. Biochem. Biophys. Res. Commun. 107, 1060-1066.
27. YONEHARA, S., YONEHARA-TAKAHASHI, M., and ISHII, A. (1983). Binding of human interferon α to cells of different sensitivities: studies with internally radiolabeled interferon retaining full biological activity. J. Virol. 45, 1168-1171.
28. SCHWABE, M., PRINCLER, G.L., AND FALTYNEK, C.R. (1988). Characterization of the human type I interferon receptor by ligand blotting. Eur. J. Immunol. 18, 2009-2014.
29. BEHLING, R.W., and JELINSKI, L.W. (1990). Importance of the membrane in ligand-receptor interactions. Biochem. Pharmacol. 40, 49-54.
30. HARLOW, E., and LANE, D. (1988). Labeling antibodies. In: Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Press, pp. 319-329.
31. MUNSON, P.J. (1992). A user's guide to LIGAND. Analytical and Biostatistical Section, Division of Computer Research and Technology, National Institutes of Health, Bethesda, MD, p. 158.
32. BAJZER, Z., and VUK-PAVLOVIC, S. (1992). Rate transition and regulatory coupling in endocytosis of interferon-α and tumor necrosis factor-α in human epithelial tumor cells. J. Cell. Biochem. 48, 203-214.
33. ZELIC, A., BAJZER, Z., and VUK-PAVLOVIC, S. (1992). ENDOCYTE, an interactive computer program for quantitative analysis of receptor-mediated endocytosis. Int. J. Biomed. Comput. 31, 59-70.
34. UZE, G., LUTFALLA, G., and MOGENSEN, K.E. (1995). α and β interferons and their receptor and their friends and relations. J. Interferon Cytokine Res. 15, 3-26.
35. COLAMONICI, O.R., PFEFFER, LM., D'ALESSANDRO, F., PLATANIAS, L.C., GREGORY, S.A., ROSOLEN, A., NORDAN, R., CRUCIANI, R.A., and DIAZ, M.O. (1992). Multichain structure of the IFN-α receptor on hematopoetic cells. J. Immunol. 148, 2126-2132.
36. MYERS, A.C., KOVACH, J.S., and VUK-PAVLOVIC, S. (1987). Binding, internalization, and intracellular processing of protein ligands. J. Biol. Chem. 262, 6494-6499.
37. RUZICKA, F.J., JACH, M.E., and BORDEN, E.C. (1987). Binding of recombinant-produced interferon-βser to human lymphoblastoid cells. J. Biol. Chem. 262, 16142-16149.
38. PFEFFER, L.M., STEBBING, N., and DONNER, D.B. (1987). Cytoskeletal association of human α-interferon-receptor complexes in interferon-sensitive and α-resistant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 84, 3249-3253.
39. PFEFFER, L.M., and TAN, Y.H. (1991). Do second messengers play a role in interferon signal transduction? TIBS 16, 321-323.
40. PREMECZ, G., MARKOVITS, A., and FÖLDES, I. (1987). A novel approach for understanding the effects of interferons - a working hypothesis. Acta Microbiol. Hung. 34, 45-55.